about
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivoImaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivoImaging of hypoxia-driven gene expression in an orthotopic liver tumor model.In vivo bioluminescence tomography with a blocking-off finite-difference SP3 method and MRI/CT coregistrationPharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer.Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo.Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivoImaging transgene activity in vivo.Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.Multimodality in vivo molecular-genetic imaging.Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastasesAdoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activityMonitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.Nuclear imaging of cancer cell therapiesComparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs).Advancing Immune and Cell-Based Therapies Through Imaging.Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo.A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection.A human-derived reporter gene for noninvasive imaging in humans: mitochondrial thymidine kinase type 2.NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice.A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging.Development of a new reporter gene system--dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier.Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.Imaging expression of cytosine deaminase-herpes virus thymidine kinase fusion gene (CD/TK) expression with [124I]FIAU and PET.In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method.Optical bioluminescence imaging of human ES cell progeny in the rodent CNS.Imaging regulation of endogenous gene expression using spliceosome-mediated trans-splicing
P50
Q27313856-92DC786E-4252-47EA-B5DB-8F58976A4A2CQ28263669-61B5DF4F-BB94-4E94-B6E9-31F9F500AEEEQ28344467-8694E984-CDE7-4642-B2B2-72D09E7A3C4CQ33305338-E2FFA014-6297-4425-B1B2-5F03448AC266Q33579639-10F30645-3461-4D3A-B818-46FA3CEF6704Q33882079-7C66E368-8D22-4D6A-90D6-59CE3D1ACEA6Q33906748-68B1012F-2654-4CB7-8B6E-2477E98D615AQ33930784-7FCE3196-FC39-45B0-B01F-1BC0C03111F1Q34597429-5587E7DF-FA54-44C9-A84B-9ADB461EE2A8Q35880086-A6B4C7C1-ECF4-4AB0-94F4-36143667E783Q35951683-F16837A4-150C-48C4-B086-5FE33D58CCB6Q36072569-FB652F50-F367-4D56-8615-7DBD5F133604Q36288143-2B37EB79-C1CA-43F4-A1C1-897B145D2D73Q36891101-DF2269C9-3698-4E2C-8332-277DF2C4AEF7Q37372552-84E17C6C-75B4-4115-BE0C-4CA68078ECB2Q37518962-13FDDF08-1FC6-4189-B22C-888BBDDFB5C3Q37693526-397B64E0-D338-4EB6-83C1-42E6515843B2Q38928915-1AE32A89-CA87-4D08-B493-80A41D5B0F37Q39167485-C1843C4D-773D-469A-AEFA-999D4FF4DED4Q39659194-0AFC82F7-7ACF-4D16-85E8-DCCC349C5A90Q39991887-42D7C17F-7F30-45D8-BB85-B8530B0AC915Q40047938-581EA9F6-7ABD-4AF2-92E4-8D7CEEF4D5C4Q40139282-68F304F2-78CC-4B66-B5CC-26258A8B8316Q40335673-16A1EDB2-155F-4BB7-8CDA-D72FB784567AQ40519873-6CFDFCB6-ADE0-4B4E-8225-3F4C0BEE213CQ40579830-21B26D69-67A4-4D5C-9CF5-0C44DDCFEA1DQ40636012-3CBBC843-DEFB-4EED-BCCE-440BBD0D9924Q40662000-5EC5C8A1-5074-4980-8591-183E01019DAAQ41497465-7DFC1CCA-6B2B-43B7-A681-C1CB918F4C8EQ41589159-427E1ED0-FB35-492D-A230-03EC7DB4E93CQ44551106-3E0CCE7A-4C56-4D44-A417-3CAF466C3036Q44965431-FDDE4F95-62E8-484C-8FBE-655AFD9C83A5Q48143717-17E7B87D-4634-46F7-85D7-F2A155A63AE3Q81451501-D6D17452-A29B-4E9E-B666-0E57538FE0EE
P50
description
hulumtues
@sq
researcher
@en
հետազոտող
@hy
name
Vladimir Ponomarev
@ast
Vladimir Ponomarev
@en
Vladimir Ponomarev
@es
Vladimir Ponomarev
@nl
Vladimir Ponomarev
@sl
type
label
Vladimir Ponomarev
@ast
Vladimir Ponomarev
@en
Vladimir Ponomarev
@es
Vladimir Ponomarev
@nl
Vladimir Ponomarev
@sl
prefLabel
Vladimir Ponomarev
@ast
Vladimir Ponomarev
@en
Vladimir Ponomarev
@es
Vladimir Ponomarev
@nl
Vladimir Ponomarev
@sl
P106
P21
P31
P496
0000-0002-9119-9128